Details of the Drug

General Information of Drug (ID: DMC7E5X)

Drug Name

T89

Synonyms

2-Propanone, 1-(5-nitro-2H-tetrazol-2-yl)-; 131394-19-9; 1-(5-nitro-1,2,3,4-tetraazol-2-yl)acetone; ZERO/000247; AC1LOTQU; ACMC-20mu2z; 2-acetonyl-5-nitrotetrazole; CTK0C0970; DTXSID40361521; MolPort-001-904-996; ZINC1084291; STK760073; SBB000169; AKOS000558886; MCULE-5436124308; 1-(5-nitrotetrazol-2-yl)propan-2-one; 2-(2-Oxopropyl)-5-nitro-2H-tetrazole; ST026974; ST023819; BAS 01313849; 1-(5-Nitro-tetrazol-2-yl)-propan-2-one; EU-0085349; 1-(5-nitro-2H-tetrazol-2-yl)propan-2-one; SR-01000523987; SR-01000523987-1

Indication

Disease Entry	ICD 11	Status	REF
Angina pectoris	BA40	Phase 3	[1]
Multiple myeloma	2A83	Phase 3	[2]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C4H5N5O3
Canonical SMILES: CC(=O)CN1N=C(N=N1)[N+](=O)[O-]
InChI: 1S/C4H5N5O3/c1-3(10)2-8-6-4(5-7-8)9(11)12/h2H2,1H3
InChIKey: RNOFFEQSFLGZHK-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 1270252
CAS Number: 131394-19-9
TTD ID: D05QUL

Repurposed Drugs (RPD)

Click to Jump to the Detailed RPD Information of This Drug

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT01659580) Phase III Trial of Dantonic (T89) Capsule to Prevent and Treat Stable Angina. U.S. National Institutes of Health.